In Treatment of Bacterial infections Ucefdys-O-LB Tablet used to treat certain bacterial infections such as sinus infections (sinusitis), chest infections such as bronchitis and pneumonia, gonorrhea (a sexually transmitted disease), and infections of the ears, skin, throat, stomach, urinary tract, and prostate gland. It works by stopping the growth of the bacteria. Ucefdys-O-LB Tablet also restores the level of good bacteria in your stomach and thus prevents stomach upset due to the antibiotics. It is advisable to continue taking it as long as it is prescribed even when you feel better, to make sure that all bacteria are killed.
It is unsafe to consume alcohol with Ucefdys
LB Tablet.
Ucefdys
LB Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Ucefdys
LB Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Ucefdys
LB Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Ucefdys
LB Tablet should be used with caution in patients with kidney disease. Dose adjustment of Ucefdys
LB Tablet may be needed. Please consult your doctor.
Ucefdys
LB Tablet should be used with caution in patients with liver disease. Dose adjustment of Ucefdys
LB Tablet may be needed. Please consult your doctor.
If you miss a dose of Ucefdys-O-LB Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Plus India || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Biotrendz Medicaments || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: MaxQure Labs || ₹14.5/tablet (25% cheaper)